US EditionPublished • loading... • Updated
Singapore Eye Research Institute tops ScholarGPS rankings in Ophthalmology
SERI leads all non-academic institutes and ranks second globally for ophthalmology based on five-year data, highlighting advancements in AI and biopharmaceutical research.
- The Singapore Eye Research Institute reported it ranked second globally and first among non‑academic ophthalmology institutes on ScholarGPS, announced in a Jan. 27, 2026 press release.
- SERI's extensive research record shows 5,942 scientific papers and external peer‑reviewed competitive grants built over nearly three decades.
- Clinical innovations include biopharmaceutical advances like Vabysmo, extending injection intervals, and SELENA+, AI screening software in the Singapore Integrated Diabetic Retinopathy Programme.
- The ranking reflects SERI's role as SNEC’s research arm, highlighting Singapore’s growing prominence and global collaborations in ophthalmology, as reported on January 27, 2026.
- ScholarGPS evaluated institutions using last five years of research output and citations, and SERI said the ranking validates its mission and plans to build on this achievement in 2026.
Insights by Ground AI
48 Articles
48 Articles
Coverage Details
Total News Sources48
Leaning Left6Leaning Right6Center15Last UpdatedBias Distribution56% Center
Bias Distribution
- 56% of the sources are Center
56% Center
L 22%
C 56%
R 22%
Factuality
To view factuality data please Upgrade to Premium
